Development of photodynamic therapy to early stage oral cancer using drug delivery system
Development of photodynamic therapy to early stage oral cancer using drug delivery system
批准号:
11470438
负责人:
TORATANI Shigeaki
金额:
$3.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
使用血卟啉衍生物(HPD)和光辐射的光动力疗法(PDT)在对抗早期癌症方面具有很高的有效性。我们已经研究了将这种疗法应用于口腔癌的治疗,对各种类型的培养的口腔癌细胞进行了研究。鳞状细胞癌(SCC)与唾液腺源性腺癌细胞(SAC)相比,对PDT具有较高的敏感性。很明显,与鳞状细胞癌相比,SAC表现出更高水平的还原型谷胱甘肽和谷胱甘肽过氧化物酶活性。对PDT敏感性降低的SCC表现出极高水平的谷胱甘肽s转移酶活性。因此,谷胱甘肽级联的功能是决定细胞光敏性的因素。此外,与SAC相比,SCC表现出细胞内药物水平的增加。因此,我们对两种细胞在无血清培养下的细胞膜脂质组成进行了研究。可见,SCC膜脂60%为磷脂(PL), SAC膜脂80%为中性脂(NL)。NL/PL比值表明SCC水平较低,而SAC水平显著较高。这些结果表明,PDT的细胞毒性与细胞内药物水平有关,这是由膜疏水性的差异引起的。因此,我们设计了与鳞状细胞癌细胞膜脂质组成相当的脂质体,构建了脂质体包裹的抗癌药物,并通过生长试验检测了鳞状细胞癌和囊状细胞癌对该脂质体的敏感性。结果,脂质体包裹的药物与单独药物或药物-脂质体混合物相比,对SCC表现出增强的细胞毒性。
英文摘要
Photodynamic therapy (PDT) using both hematoporphyrin derivative (HPD) and photoradiation has had a high rate of effectiveness in combatting early stage cancers. We have studied, to apply this therapy to treatment of oral cancer, on verious type of cultured carcinoma cells derived from oral cancers.It has been revealed that squamous cell carcinoma cells (SCC) exhibited high sensitivity to PDT in comparison with salivary gland-derived adenocarcinoma cells (SAC). It became clear that SAC exhibited an increased level of reduced glutathion and glutathion peroxidase activity in comparison to those of SCC.The SCC which showed decreased sensitivity to PDT, exhibited a extremerly high level of glutathion S-transferase activity. Consequenly, the function of glutathion cascade were factors determining photosensitivity of the cells. In addition, the SCC demonstrated an increased intracellular level of drug compare to that SAC.So we have investigated lipid composition of cell-membrane of both cells under serum-free culture. It became evident that 60% of membrane lipids of SCC was phospholipids (PL) and 80% of those of SAC was neutral lipids (NL). The NL/PL ratio indicated that SCC showed low levels but SAC showed remarkably high levels. These result indicated that the cytotoxity of PDT correlated with the intracellular levels of drug resulted from the difference of membrane hydrophobicity.Thus, we have designed liposome which is comparable to the lipid composition of SCC cell membrane, constructed the liposome-entrapped anti-cancer drugs and examined sensitivity to this liposome of both SCC and SAC by growth assay. As the result, the liposome-entrapped drug exhibited enhanced cytotoxicity on SCC compare to either drug alone or drug-liposome mixture.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shigeaki TORATANI: "Effect of photodynamic action with pheophorbide-a on human oral carcinoma cells in serum-free culture."Tiss.Cult.Res.Commun.. 18・4. 345-352 (1999)
Shigeaki TORATANI:“脱镁叶绿酸-a 的光动力作用对无血清培养物中人口腔癌细胞的影响”。Tiss.Cult.Res.Commun. 18・4 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toratani, S., Kimoto, N., Shinki, T.and Okamoto, T.: "Effect of photodynamic action with pheophorbide-a on human oral carcinoma cells in serum-free culture."Tiss.Cult.Res.Commun.. 18. 345-352 (1999)
Toratani, S.、Kimoto, N.、Shinki, T. 和 Okamoto, T.:“脱镁叶绿酸-a 的光动力作用对无血清培养物中人口腔癌细胞的影响。”Tiss.Cult.Res.Commun.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shigeaki TORATANI: "Effect of photodynamic action with pheophorbide-a on human oral carcinoma cells in serum-free culture."Tiss.Cult.Res.Commun.. 18. 345-352 (1999)
Shigeaki TORATANI:“脱镁叶绿酸-a 的光动力作用对无血清培养物中人口腔癌细胞的影响。”Tiss.Cult.Res.Commun.. 18. 345-352 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S. Toratani et al.: "Effect of photodynamic therapy action with pheophorbide-a on human oral carcinoma cells in serum-free culture"Tiss. Cult. Res. Commun.. 18・4. 345-352 (1999)
S. Toratani 等:“脱镁叶绿酸-a 对无血清培养物中的人口腔癌细胞的影响”Tiss Commun. 18・4 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Proteomic analysis of molecular-targeted therapy against KGFR of salivary gland carcinomas
-
批准号:18592184
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.52万
-
财政年份:2006
-
负责人:TORATANI Shigeaki
-
依托单位:
Development of targeting therapy using specific difference of lipid composition of oral cancer cell, resistant
-
批准号:13672098
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:TORATANI Shigeaki
-
依托单位:
New targeting therapy with complex of liposome, consist of comparable lipid composition of oral cancer cells, and anti-EGF receptor antibody.
-
批准号:10557191
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.78万
-
财政年份:1998
-
负责人:TORATANI Shigeaki
-
依托单位:
Development of new drug deliverty system with liposome consist of comparable to the lipid composition of oral cancer cancer cell membrane
-
批准号:08672311
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:TORATANI Shigeaki
-
依托单位:
国内基金
海外基金
Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
-
批准号:82272000
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:杨秀华
-
依托单位:
基于Gd-HPDO3A@Liposome-Ga-68的PET/MR用于肝肿瘤增强显像及酸碱微环境检测
-
批准号:81701761
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:李潇
-
依托单位: